Can weaker lung cancer patients handle same powerful treatment?
NCT ID NCT04253964
First seen Mar 23, 2026 · Last updated May 20, 2026 · Updated 10 times
Summary
This study looks at whether non-small cell lung cancer patients with a lower performance status (meaning they are less active or have more symptoms) can benefit from the same first-line chemo/immunotherapy as healthier patients. Researchers will compare how long the cancer stays under control, survival, side effects, and quality of life between the two groups. The goal is to see if it's safe and effective to treat these patients with the same standard regimen.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONSMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Wake Forest Baptist Comprehensive Cancer Center
RECRUITINGWinston-Salem, North Carolina, 27105, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.